Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C44H56N8O7 |
Molecular Weight | 808.9648 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](C)N(C)C(=O)[C@H](CC5=CC=CC=C5)NC1=O
InChI
InChIKey=NPJIOCBFOAHEDO-AVWFULIKSA-N
InChI=1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1
Seglitide (previously known as L363,586 or MK-678), a cyclic, hexapeptide analog of somatostatin-14, is a somatostatin receptor 2 (SSTR2) agonist. This compound was studied in Alzheimer's disease. Besides, it possessed inhibitory actions on rat growth hormone (GH) release and thus could have a role in the treatment of acromegaly. Intravenous and intranasal administration of seglitide to diabetic subjects was effective in reducing both fasting and postprandial hyperglycemia. Thus, this compound could be useful in the control of unstable diabetes. In addition, preclinical studies have shown that seglitide had potential as a treatment for diabetic retinopathy and macular degeneration. However, the further studied of this compound were discontinued.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. | 1993 Jun |
|
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). | 1994 Dec |
|
Binding properties of somatostatin receptor subtypes. | 1996 Aug |
|
The elucidation of somatostatin receptor functions: a current view. | 1998 |
|
[125I]Tyr10-cortistatin14 labels all five somatostatin receptors. | 1998 May |
|
[125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. | 1998 May 8 |
|
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. | 1998 Sep 1 |
|
Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies. | 1999 Nov |
|
Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor. | 2000 Jun 8 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C62799
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90231068
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
C152317
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
81377-02-8
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
5P57R7IR6J
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
100000084087
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
6146
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
SUB10473MIG
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
C040968
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
5311430
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY | |||
|
CHEMBL311695
Created by
admin on Fri Dec 15 16:22:34 GMT 2023 , Edited by admin on Fri Dec 15 16:22:34 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)